CD44 and neoplasm: Using this knowledge, we identified an effector-like subset expressing CXCR6, along with high KLRD1 and CD44 expression.73,74 Despite the different surface receptor, we observed similar phenotypic changes in PBAF-deleted CD8+ T cells from an LCMV Cl13 infection and tumor model.